{
  "basic_data": [
    {
      "hpscreg_name": "MCRIi019-A-6",
      "cell_line_alt_name": "iPSC COL2A1 p.R719C; MCRIi019-A-6",
      "cell_type": "hiPSC",
      "frozen": "True"
    }
  ],
  "generator": [
    {
      "group": "Murdoch Children's Research Institute, Melbourne, Australia"
    }
  ],
  "contact": [
    {
      "group": "Murdoch Children's Research Institute",
      "first_name": "Matthew",
      "last_name": "Shoulders",
      "name_initials": "D",
      "e_mail": "mshoulde@mit.edu",
      "phone_number": "Missing"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2023.103020",
      "journal": "Stem Cell Research",
      "title": "Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis",
      "first_author": "Kathryn M. Yammine",
      "last_author": "Matthew D. Shoulders",
      "year": "2023",
      "pmid": "Missing"
    }
  ],
  "donor": [
    {
      "age": "NEO",
      "sex": "Female",
      "disease_name": "Missing",
      "disease_description": "Missing"
    }
  ],
  "genomic_modifications": [
    {
      "mutation_type": "Knock in",
      "cytoband": "12q13.11",
      "delivery_method": "Crispr/Cas9",
      "description": "Heterozygous COL2A1 c.2155C>T (p.R719C) mutation introduced by CRISPR/Cas9 and ODN repair template",
      "genotype": "Heterozygous COL2A1 c.2155C>T",
      "loci_name": "COL2A1"
    }
  ],
  "differentiation_results": [
    {
      "cell_type": "Endoderm",
      "show_potency": "True",
      "marker_list": "Sox17",
      "method_used": "Immunocytochemistry",
      "description": "In vitro directed differentiation"
    },
    {
      "cell_type": "Mesoderm",
      "show_potency": "True",
      "marker_list": "Brachyury",
      "method_used": "Immunocytochemistry",
      "description": "In vitro directed differentiation"
    },
    {
      "cell_type": "Ectoderm",
      "show_potency": "True",
      "marker_list": "Nestin; PAX6",
      "method_used": "Immunocytochemistry",
      "description": "In vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "20",
      "karyotype": "46XX",
      "karyotype_method": "G-banding",
      "summary": "G-band karyotyping at 0.50 Mb resolution, 20 metaphase cells counted, no chromosomal abnormalities detected."
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "induced pluripotent cell line MCRIi019-A",
      "i_source_cell_origin_term": "dermal fibroblast-derived human induced pluripotent cell",
      "derivation_year": "2020",
      "non_int_vector": "Episomal",
      "non_int_vector_name": "Episomal vectors"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "HREC/51321/A",
      "approval_date": "Missing",
      "institutional_HREC": "Human Research Ethics Committee of the Royal Children\u2019s Hospital (HREC/51321/A), Victoria, Australia"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "Enzymatically"
    }
  ]
}